NovoCure’s (NVCR) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright reissued their buy rating on shares of NovoCure (NASDAQ:NVCR – Free Report) in a research report released on Thursday,Benzinga reports. They currently have a $30.00 price objective on the medical equipment provider’s stock. Several other research firms have also recently weighed in on NVCR. Wedbush reaffirmed an “outperform” rating and issued a $24.00 […]
More Stories
Invesque (TSE:IVQ.U) Stock Price Up 20% – What’s Next?
Shares of Invesque Inc (TSE:IVQ.U – Get Free Report) were up 20% during mid-day trading on Saturday . The stock...
GGL Resources (CVE:GGL) Stock Price Up 33.3% – Should You Buy?
GGL Resources Corp. (CVE:GGL – Get Free Report)’s share price rose 33.3% during mid-day trading on Saturday . The stock...
Chanson International (NASDAQ:CHSN) versus Nestlé (OTCMKTS:NSRGY) Critical Survey
Nestlé (OTCMKTS:NSRGY – Get Free Report) and Chanson International (NASDAQ:CHSN – Get Free Report) are both consumer staples companies, but...
Arctic Star Exploration (CVE:ADD) Trading Up 50% – Still a Buy?
Shares of Arctic Star Exploration Corp. (CVE:ADD – Get Free Report) shot up 50% during mid-day trading on Saturday ....
Head to Head Comparison: iTeos Therapeutics (NASDAQ:ITOS) & Invivyd (NASDAQ:IVVD)
Invivyd (NASDAQ:IVVD – Get Free Report) and iTeos Therapeutics (NASDAQ:ITOS – Get Free Report) are both small-cap medical companies, but...
Oracle Power (LON:ORCP) Trading Down 14.3% – Here’s Why
Oracle Power plc (LON:ORCP – Get Free Report)’s share price traded down 14.3% during mid-day trading on Saturday . The...